These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4803984)

  • 21. Pediatric Phase I clinical trials: ethical issues and nursing considerations.
    Cogliano-Shutta NA
    Oncol Nurs Forum; 1986; 13(2):29-32. PubMed ID: 3633571
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of leukoconcentration for evaluation of the effectiveness of cytostatic therapy of acute leukemia].
    Gal'ianova GN; Frenkel' MA; Solov'eva EA; Streliukhina NV
    Lab Delo; 1969; 4():240-3. PubMed ID: 4184930
    [No Abstract]   [Full Text] [Related]  

  • 23. Technics and ethics in managing acute leukemia.
    Reizenstein P
    Acta Med Scand; 1977; 202(1-2):1-4. PubMed ID: 268927
    [No Abstract]   [Full Text] [Related]  

  • 24. [Progress in the treatment of acute leukemia: status in 1971].
    Jungi WF; Senn HJ
    Schweiz Rundsch Med Prax; 1971 Dec; 60(52):1737-46. PubMed ID: 5289956
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of the treatment of acute leukemia in relation to the sensitivity of leukemia cells to cytostatic drugs].
    Klimenko VI; Romanova AF; Zverkova AS; Evtukh VP
    Vrach Delo; 1988 Jun; (6):86-8. PubMed ID: 3420922
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trials of newly developed anti-cancer agents in children with acute leukemia.
    Singh TP
    Contemp Clin Trials; 2006 Dec; 27(6):493. PubMed ID: 17056299
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II evaluation of diglycoaldehyde (Inox) in children with acute leukemia: a children's cancer study group report.
    Higgins GR; Finklestein J; Krivit W; Hammond D
    Cancer Treat Rep; 1980; 64(4-5):625-8. PubMed ID: 7427952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy of acute leukemia from the viewpoint of the action mechanism of antitumor agents.
    Nakamura T
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1022-33. PubMed ID: 7331684
    [No Abstract]   [Full Text] [Related]  

  • 29. [Importance of determination of phases of mitotic cycle of cells in the treatment of acute leukemia (literature survey)].
    Gerasimova NA; Egorov LV; Kozinets GI; Terent'eva EI
    Probl Gematol Pereliv Krovi; 1976 Apr; 21(4):42-6. PubMed ID: 799786
    [No Abstract]   [Full Text] [Related]  

  • 30. Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL).
    Carella AM; Santini G; Martinengo M; Nati S; Giordano D; Congiu A; Cerri R; Damasio E; Risso M; Rossi E
    Haematologica; 1985; 70(1):39-43. PubMed ID: 2408974
    [No Abstract]   [Full Text] [Related]  

  • 31. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K; Kaneko Y; Maseki N; Kumai R; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1453-7. PubMed ID: 4015120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the treatment of acute leukemia in children.
    Evans AE
    IMJ Ill Med J; 1969 Jun; 135(6):677-84 passim. PubMed ID: 4389072
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia.
    Daghestani AN; Arlin ZA; Leyland-Jones B; Gee TS; Kempin SJ; Mertelsmann R; Budman D; Schulman P; Baratz R; Williams L
    Cancer Res; 1985 Mar; 45(3):1408-12. PubMed ID: 3855696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute leukemia results of treatment at a provincial hospital].
    Magnusson S; Möller BH
    Lakartidningen; 1980 Oct; 77(40):3516-7. PubMed ID: 7453351
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemotherapy of acute leukemia].
    Nakamura T; Ueda T
    Rinsho Byori; 1984 Sep; 32(9):967-74. PubMed ID: 6394825
    [No Abstract]   [Full Text] [Related]  

  • 36. [Phase II study of mitoxantrone for hematologic malignancies].
    Ueoka H; Ueno K; Yamane T; Toyoda K; Endo H; Nishihara R; Takahashi I; Ohnoshi T; Kitajima K; Kimura I
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2399-402. PubMed ID: 6639101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of acute leukemia].
    Barry A; Delage JM
    Union Med Can; 1970 Jun; 99(6):1045-54. PubMed ID: 5280031
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic strategy in acute leukaemias.
    Sen NN
    J Indian Med Assoc; 1977 Feb; 68(4):82-3. PubMed ID: 908834
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prognostic factors and new drugs in acute non-lymphoblastic leukemia].
    Levy A; Pinkhas J
    Harefuah; 1983 Oct; 105(8):236-8. PubMed ID: 6681391
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical trials with bis-dioxopiperazine propane (ICRF 159; NSC 129, 943) in acute leukaemias.
    Krepler P; Pawlowsky J
    Osterr Z Onkol; 1975; 2(4):112-4. PubMed ID: 772517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.